Dongsheng Zhang

Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study.

Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study.

Journal: Molecular cancer

Published: May 29, 2025

Signature Construction Associated with Tumor-Infiltrating Macrophages Identifies IRF8 as a Novel Biomarker for Immunotherapy in Advanced Gastric Cancer.

Signature Construction Associated with Tumor-Infiltrating Macrophages Identifies IRF8 as a Novel Biomarker for Immunotherapy in Advanced Gastric Cancer.

Journal: International journal of molecular sciences

Published: December 10, 2024

Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial.

Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial.

Journal: The Lancet. Oncology

Published: August 14, 2024

Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.

Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.

Journal: Cancer immunology, immunotherapy : CII

Published: April 07, 2024

Clinical benefit of continuation of PD-1 inhibitors after progression on first-line chemoimmunotherapy in metastatic gastric cancer and biomarker exploration.

Clinical benefit of continuation of PD-1 inhibitors after progression on first-line chemoimmunotherapy in metastatic gastric cancer and biomarker exploration.

Journal: BMC cancer

Published: February 08, 2024

Spatial transcriptomics of gastric cancer brain metastasis reveals atypical vasculature strategies with supportive immune profiles.

Spatial transcriptomics of gastric cancer brain metastasis reveals atypical vasculature strategies with supportive immune profiles.

Journal: Gastroenterology report

Published: November 25, 2023

Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study.

Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study.

Journal: Cancer communications (London, England)

Published: April 27, 2022

HMMR promotes peritoneal implantation of gastric cancer by increasing cell-cell interactions.

HMMR promotes peritoneal implantation of gastric cancer by increasing cell-cell interactions.

Journal: Discover oncology

Published: April 15, 2022

High Prevalence of Antimicrobial Resistance and Integron Gene Cassettes in Multi-Drug-Resistant Klebsiella pneumoniae Isolates From Captive Giant Pandas (Ailuropoda melanoleuca).

High Prevalence of Antimicrobial Resistance and Integron Gene Cassettes in Multi-Drug-Resistant Klebsiella pneumoniae Isolates From Captive Giant Pandas (Ailuropoda melanoleuca).

Journal: Frontiers in microbiology

Published: October 25, 2021

USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.

USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.

Journal: Nature communications

Published: October 13, 2021

The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors.

The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors.

Journal: Molecular cancer

Published: August 10, 2020

Prognostic significance of interferon regulating factor 4 in esophageal squamous cell carcinoma.

Prognostic significance of interferon regulating factor 4 in esophageal squamous cell carcinoma.

Journal: Biochemical and biophysical research communications

Published: October 12, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026